Updates on Management of Gastric Cancer

Fabian Johnston, Michael Beckman

Research output: Contribution to journalReview article

Abstract

Purpose of Review: Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common, even with complete resection. Recent Findings: Advances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherapy and chemoradiation, and targeted and immune therapies have led to the current multidisciplinary approach to gastric adenocarcinoma. Summary: Treatment of gastric cancer is rapidly evolving in an effort to combat this challenging disease.

Original languageEnglish (US)
Article number67
JournalCurrent oncology reports
Volume21
Issue number8
DOIs
StatePublished - Aug 1 2019

Fingerprint

Stomach Neoplasms
Stomach
Adenocarcinoma
Peritoneal Diseases
Therapeutics
Recurrence
Drug Therapy
Neoplasms

Keywords

  • CYTO-CHIP
  • FLOT
  • Gastric adenocarcinoma
  • Gastric cancer
  • HIPEC
  • Siewert type III

ASJC Scopus subject areas

  • Oncology

Cite this

Updates on Management of Gastric Cancer. / Johnston, Fabian; Beckman, Michael.

In: Current oncology reports, Vol. 21, No. 8, 67, 01.08.2019.

Research output: Contribution to journalReview article

Johnston, Fabian ; Beckman, Michael. / Updates on Management of Gastric Cancer. In: Current oncology reports. 2019 ; Vol. 21, No. 8.
@article{012fd6d0952e40e6ad4bbd6005cfc83a,
title = "Updates on Management of Gastric Cancer",
abstract = "Purpose of Review: Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common, even with complete resection. Recent Findings: Advances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherapy and chemoradiation, and targeted and immune therapies have led to the current multidisciplinary approach to gastric adenocarcinoma. Summary: Treatment of gastric cancer is rapidly evolving in an effort to combat this challenging disease.",
keywords = "CYTO-CHIP, FLOT, Gastric adenocarcinoma, Gastric cancer, HIPEC, Siewert type III",
author = "Fabian Johnston and Michael Beckman",
year = "2019",
month = "8",
day = "1",
doi = "10.1007/s11912-019-0820-4",
language = "English (US)",
volume = "21",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "8",

}

TY - JOUR

T1 - Updates on Management of Gastric Cancer

AU - Johnston, Fabian

AU - Beckman, Michael

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Purpose of Review: Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common, even with complete resection. Recent Findings: Advances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherapy and chemoradiation, and targeted and immune therapies have led to the current multidisciplinary approach to gastric adenocarcinoma. Summary: Treatment of gastric cancer is rapidly evolving in an effort to combat this challenging disease.

AB - Purpose of Review: Gastric adenocarcinoma is the fifth most common and the third most lethal cancer worldwide. Surgery is the only chance of cure, but recurrence is common, even with complete resection. Recent Findings: Advances in diagnosis and staging, genomic classification, surgical resection and treatment of peritoneal disease, systemic chemotherapy and chemoradiation, and targeted and immune therapies have led to the current multidisciplinary approach to gastric adenocarcinoma. Summary: Treatment of gastric cancer is rapidly evolving in an effort to combat this challenging disease.

KW - CYTO-CHIP

KW - FLOT

KW - Gastric adenocarcinoma

KW - Gastric cancer

KW - HIPEC

KW - Siewert type III

UR - http://www.scopus.com/inward/record.url?scp=85067971115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067971115&partnerID=8YFLogxK

U2 - 10.1007/s11912-019-0820-4

DO - 10.1007/s11912-019-0820-4

M3 - Review article

C2 - 31236716

AN - SCOPUS:85067971115

VL - 21

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 8

M1 - 67

ER -